The Stanley Medical Research Institute (SMRI) is a nonprofit organization supporting research on the causes of, and treatments for, schizophrenia and bipolar disorder. Since it began in 1989, SMRI has supported more than $550 million in research in over 30 countries.
Schizophrenia and bipolar disorder are psychiatric disorders that affect more than 6 million people at any given time in the United States. The neuroscience revolution has brought with it great opportunities for increased understanding of brain diseases such as schizophrenia and bipolar disorder and SMRI has been on the leading edge of this exciting research.
SMRI funds Treatment Trials of biological interventions which may improve the symptoms of individuals with schizophrenia or bipolar disorder. SMRI also provides a list of Repurposed Drugs which are medicines approved for other medical conditions, but may have potential therapeutic benefits for patients who have not responded to traditional psychiatric medication. SMRI provides updates on 9 repurposed drugs that SMRI has supported treatment trials for.